Results 61 to 70 of about 2,077 (188)

Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 99-108, April 2026.
Abstract Background Breast cancer survivors (BCS) often experience more severe symptoms of genitourinary syndrome of menopause (GSM). As estrogen‐based hormonal therapy is generally avoided in BCS, physical energy methods may offer promising non‐hormonal alternatives.
Nicoli Serquiz   +7 more
wiley   +1 more source

Evidence‐ and consensus‐based guideline on lichen sclerosus

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 566-584, April 2026.
Summary The German‐language, consensus‐ and evidence‐based S3 guideline on lichen sclerosus (LS) was developed based on the European “EuroGuiDerm Guideline on lichen sclerosus” under the leadership of the German Dermatological Society (DDG) and the German Society for Gynecology and Obstetrics (DGGG).
Gudula Kirtschig   +25 more
wiley   +1 more source

Elasticity Improvement and Water Loss Prevention in Vulvar Skin by Topical Nonhormonal Moisturizer

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 117-123, March 2026.
Effect of topical non‐hormonal moisturizer on the vulva in postmenopausal women. Moisturizer is completely absorbed. Water loss from vulva is reduced by 51% compared to baseline measurements. Elasticity is improved by 21% compared to baseline measurements.
Hans Christian Wulf   +2 more
wiley   +1 more source

Muscle Dysfunction and Bone Loss in a Woman With Cystic Fibrosis and Obesity Treated With Glucagon‐Like Peptide 1 Agonist: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
Cystic fibrosis (CF) modulator therapies can lead to rapid and excessive weight gain. Obesity in CF can lead to undesirable metabolic complications including type 2 diabetes. Therefore, glucagon‐like peptide 1 (GLP‐1) agonists which can facilitate weight loss and improve metabolic profiles are increasingly prescribed to people with CF.
Shanal Kumar   +4 more
wiley   +1 more source

An Exploration of the Views and Perspectives of Australian Trans and Gender Diverse Individuals About Transvaginal Ultrasound

open access: yesPerspectives on Sexual and Reproductive Health, Volume 58, Issue 1, Page 77-90, March 2026.
ABSTRACT Background Transvaginal ultrasound (TVS) is used routinely in gynecological care in Australia to manage gynecological health concerns. Typically, TVS is well tolerated by patients, with low levels of discomfort reported. Trans and gender diverse people assigned female at birth may experience gender dysphoria or testosterone‐related anatomical ...
Caitlyn Wilke   +5 more
wiley   +1 more source

Research Progress in the Treatment of Vaginitis With Bioactive Compounds: Targeting of Vaginal Microflora

open access: yesMicrobiologyOpen, Volume 15, Issue 1, February 2026.
Mechanism diagram of the effect of herbal medicine on vaginitis. Herbal medicines mainly combat vaginitis by (A) inhibiting bacteria, (B) inhibiting fungi, (C) acting on the cilia of Trichomonas, (D) inhibiting virus replication, (E) repairing the mucosa, (F) enhancing immunity, and (G) maintaining the microecological balance.
Yongming Li   +4 more
wiley   +1 more source

Post-menopausal vulvovaginal atrophy — an overview of the current treatment options

open access: yes, 2018
Sex hormone deficiency in post-menopausal women causes changes in the lower urinary tract. Vulvovaginal atrophy is a pathology resulting from those changes. VVA has a negative effect on the quality of life therefore prompting a search for new therapeutic
Siekierski, Bogumił Paweł; St Sophia Hospital in Warsaw, Żelazna 90 St., 01-004 Warsaw, Poland   +3 more
core   +1 more source

Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial

open access: yes, 2020
International audienceBackground and objective: Quality of life preservation after anti-cancer therapy is a major challenge for breast cancer survivors. Approximately 42-70% of patients who receive systemic therapy for breast cancer, including endocrine ...
Kalsoum, S.   +9 more
core   +1 more source

Probiotic‐Based Materials as Living Therapeutics

open access: yesAdvanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio   +2 more
wiley   +1 more source

Role of Gynecologic Findings in Interstitial Cystitis/Bladder Pain Syndrome: A Consensus

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 39-45, January 2026.
ABSTRACT Objective To evaluate the role of gynecologic findings in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by reviewing current international guidelines and identifying relevant gynecologic co‐morbidities. Methods This consensus statement was developed through a systematic four‐phase process: (1) comprehensive literature review across ...
Marie E. Sullivan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy